Latest news with #DnaGroup
Yahoo
12-05-2025
- Business
- Yahoo
Middle Eastern Penny Stocks With Market Caps Over US$60M To Watch
As the Middle Eastern markets navigate the complexities of global trade tensions, particularly between the U.S. and China, investors are keeping a close eye on regional indices that have shown mixed performances. In this context, penny stocks—though an older term—continue to represent smaller or less-established companies that might offer significant value to discerning investors. By focusing on those with solid financials and growth potential, these stocks can provide unique opportunities for those looking beyond traditional investment options. Name Share Price Market Cap Financial Health Rating Thob Al Aseel (SASE:4012) SAR4.13 SAR1.58B ★★★★★★ Keir International (SASE:9542) SAR3.92 SAR474M ★★★★★☆ Dna Group (T.R.) (TASE:DNA) ₪0.999 ₪123.04M ★★★★★★ Alarum Technologies (TASE:ALAR) ₪2.446 ₪171.3M ★★★★★★ Oil Refineries (TASE:ORL) ₪0.922 ₪2.87B ★★★★★☆ Tgi Infrastructures (TASE:TGI) ₪2.222 ₪165.19M ★★★★★★ Sharjah Cement and Industrial Development (PJSC) (ADX:SCIDC) AED0.709 AED425.78M ★★★★★★ Dubai National Insurance & Reinsurance (P.S.C.) (DFM:DNIR) AED3.40 AED390.39M ★★★★★★ E7 Group PJSC (ADX:E7) AED1.03 AED2.1B ★★★★★★ Dubai Investments PJSC (DFM:DIC) AED2.36 AED10.03B ★★★★☆☆ Click here to see the full list of 95 stocks from our Middle Eastern Penny Stocks screener. Let's take a closer look at a couple of our picks from the screened companies. Simply Wall St Financial Health Rating: ★★★★☆☆ Overview: Ihlas Yayin Holding A.S. operates in Turkey through its subsidiaries, focusing on media, publishing, and advertising businesses with a market cap of TRY940.50 million. Operations: The company generates revenue from several segments, including Journalism and Printing Works (TRY1.77 billion), News Agencies (TRY389.08 million), and TV Services and Other (TRY318.35 million). Market Cap: TRY940.5M Ihlas Yayin Holding's financial landscape presents a mixed picture for investors considering penny stocks. The company's revenue of TRY2.48 billion reflects a slight decline from the previous year, while it remains unprofitable with a net loss of TRY227.23 million. Despite this, the company has more cash than debt and its short-term assets exceed short-term liabilities, indicating some financial resilience. However, its cash runway is less than one year if free cash flow continues to shrink at historical rates. The board's average tenure of 5.3 years suggests experienced governance amidst these challenges. Jump into the full analysis health report here for a deeper understanding of Ihlas Yayin Holding. Gain insights into Ihlas Yayin Holding's historical outcomes by reviewing our past performance report. Simply Wall St Financial Health Rating: ★★★★★☆ Overview: Metro Ticari ve Mali Yatirimlar Holding A.S. operates as a diversified holding company with various business interests, and it has a market capitalization of TRY1.33 billion. Operations: The company generates revenue primarily from its Transportation - Railroads segment, amounting to TRY28.73 million. Market Cap: TRY1.33B Metro Ticari ve Mali Yatirimlar Holding, with a market cap of TRY1.33 billion, operates without debt and has not diluted shareholders recently. Despite generating TRY28.73 million in revenue primarily from its railroads segment, the company remains unprofitable with a significant net loss of TRY1,085.84 million for the past year. Its short-term assets exceed liabilities but fall short against long-term obligations of TRY219.6 million. The firm boasts a cash runway exceeding three years if current free cash flow remains stable, supported by an experienced board averaging 4.8 years in tenure amidst financial challenges and volatility stability over the past year. Unlock comprehensive insights into our analysis of Metro Ticari ve Mali Yatirimlar Holding stock in this financial health report. Assess Metro Ticari ve Mali Yatirimlar Holding's previous results with our detailed historical performance reports. Simply Wall St Financial Health Rating: ★★★★☆☆ Overview: Bonus BioGroup Ltd. is a clinical-stage biotechnology company focused on developing tissue engineering and cell therapy products, with a market cap of ₪230.08 million. Operations: Bonus BioGroup Ltd. currently has no reported revenue segments. Market Cap: ₪230.08M Bonus BioGroup Ltd., with a market cap of ₪230.08 million, is a pre-revenue clinical-stage biotechnology company focusing on tissue engineering and cell therapy products. The firm recently secured FDA clearance for a Phase III clinical study of MesenCure™, targeting respiratory distress in severely ill patients. Despite its potential, the company faces financial challenges, including short-term assets that do not cover liabilities and a cash runway limited to three months before recent capital raising efforts. While debt-free and led by an experienced management team, Bonus BioGroup's stock remains highly volatile with no significant revenue streams yet established. Click here and access our complete financial health analysis report to understand the dynamics of Bonus BioGroup. Gain insights into Bonus BioGroup's past trends and performance with our report on the company's historical track record. Gain an insight into the universe of 95 Middle Eastern Penny Stocks by clicking here. Curious About Other Options? This technology could replace computers: discover the 22 stocks are working to make quantum computing a reality. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include IBSE:IHYAY IBSE:METRO and TASE:BONS. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
12-05-2025
- Business
- Yahoo
Middle Eastern Penny Stocks With Market Caps Over US$60M To Watch
As the Middle Eastern markets navigate the complexities of global trade tensions, particularly between the U.S. and China, investors are keeping a close eye on regional indices that have shown mixed performances. In this context, penny stocks—though an older term—continue to represent smaller or less-established companies that might offer significant value to discerning investors. By focusing on those with solid financials and growth potential, these stocks can provide unique opportunities for those looking beyond traditional investment options. Name Share Price Market Cap Financial Health Rating Thob Al Aseel (SASE:4012) SAR4.13 SAR1.58B ★★★★★★ Keir International (SASE:9542) SAR3.92 SAR474M ★★★★★☆ Dna Group (T.R.) (TASE:DNA) ₪0.999 ₪123.04M ★★★★★★ Alarum Technologies (TASE:ALAR) ₪2.446 ₪171.3M ★★★★★★ Oil Refineries (TASE:ORL) ₪0.922 ₪2.87B ★★★★★☆ Tgi Infrastructures (TASE:TGI) ₪2.222 ₪165.19M ★★★★★★ Sharjah Cement and Industrial Development (PJSC) (ADX:SCIDC) AED0.709 AED425.78M ★★★★★★ Dubai National Insurance & Reinsurance (P.S.C.) (DFM:DNIR) AED3.40 AED390.39M ★★★★★★ E7 Group PJSC (ADX:E7) AED1.03 AED2.1B ★★★★★★ Dubai Investments PJSC (DFM:DIC) AED2.36 AED10.03B ★★★★☆☆ Click here to see the full list of 95 stocks from our Middle Eastern Penny Stocks screener. Let's take a closer look at a couple of our picks from the screened companies. Simply Wall St Financial Health Rating: ★★★★☆☆ Overview: Ihlas Yayin Holding A.S. operates in Turkey through its subsidiaries, focusing on media, publishing, and advertising businesses with a market cap of TRY940.50 million. Operations: The company generates revenue from several segments, including Journalism and Printing Works (TRY1.77 billion), News Agencies (TRY389.08 million), and TV Services and Other (TRY318.35 million). Market Cap: TRY940.5M Ihlas Yayin Holding's financial landscape presents a mixed picture for investors considering penny stocks. The company's revenue of TRY2.48 billion reflects a slight decline from the previous year, while it remains unprofitable with a net loss of TRY227.23 million. Despite this, the company has more cash than debt and its short-term assets exceed short-term liabilities, indicating some financial resilience. However, its cash runway is less than one year if free cash flow continues to shrink at historical rates. The board's average tenure of 5.3 years suggests experienced governance amidst these challenges. Jump into the full analysis health report here for a deeper understanding of Ihlas Yayin Holding. Gain insights into Ihlas Yayin Holding's historical outcomes by reviewing our past performance report. Simply Wall St Financial Health Rating: ★★★★★☆ Overview: Metro Ticari ve Mali Yatirimlar Holding A.S. operates as a diversified holding company with various business interests, and it has a market capitalization of TRY1.33 billion. Operations: The company generates revenue primarily from its Transportation - Railroads segment, amounting to TRY28.73 million. Market Cap: TRY1.33B Metro Ticari ve Mali Yatirimlar Holding, with a market cap of TRY1.33 billion, operates without debt and has not diluted shareholders recently. Despite generating TRY28.73 million in revenue primarily from its railroads segment, the company remains unprofitable with a significant net loss of TRY1,085.84 million for the past year. Its short-term assets exceed liabilities but fall short against long-term obligations of TRY219.6 million. The firm boasts a cash runway exceeding three years if current free cash flow remains stable, supported by an experienced board averaging 4.8 years in tenure amidst financial challenges and volatility stability over the past year. Unlock comprehensive insights into our analysis of Metro Ticari ve Mali Yatirimlar Holding stock in this financial health report. Assess Metro Ticari ve Mali Yatirimlar Holding's previous results with our detailed historical performance reports. Simply Wall St Financial Health Rating: ★★★★☆☆ Overview: Bonus BioGroup Ltd. is a clinical-stage biotechnology company focused on developing tissue engineering and cell therapy products, with a market cap of ₪230.08 million. Operations: Bonus BioGroup Ltd. currently has no reported revenue segments. Market Cap: ₪230.08M Bonus BioGroup Ltd., with a market cap of ₪230.08 million, is a pre-revenue clinical-stage biotechnology company focusing on tissue engineering and cell therapy products. The firm recently secured FDA clearance for a Phase III clinical study of MesenCure™, targeting respiratory distress in severely ill patients. Despite its potential, the company faces financial challenges, including short-term assets that do not cover liabilities and a cash runway limited to three months before recent capital raising efforts. While debt-free and led by an experienced management team, Bonus BioGroup's stock remains highly volatile with no significant revenue streams yet established. Click here and access our complete financial health analysis report to understand the dynamics of Bonus BioGroup. Gain insights into Bonus BioGroup's past trends and performance with our report on the company's historical track record. Gain an insight into the universe of 95 Middle Eastern Penny Stocks by clicking here. Curious About Other Options? This technology could replace computers: discover the 22 stocks are working to make quantum computing a reality. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include IBSE:IHYAY IBSE:METRO and TASE:BONS. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@
Yahoo
09-05-2025
- Business
- Yahoo
Middle Eastern Penny Stocks With Market Caps Under US$1B
The Middle East stock markets have recently shown mixed performance, influenced by corporate earnings announcements and the anticipation of U.S.-China trade talks. In such a fluctuating environment, investors often look for opportunities in less conventional areas like penny stocks. Although the term 'penny stocks' might seem outdated, these smaller or newer companies can offer significant potential when they possess strong financials. Name Share Price Market Cap Financial Health Rating Thob Al Aseel (SASE:4012) SAR3.98 SAR1.59B ★★★★★★ Keir International (SASE:9542) SAR3.92 SAR474M ★★★★★☆ Dna Group (T.R.) (TASE:DNA) ₪1.009 ₪124.27M ★★★★★★ Alarum Technologies (TASE:ALAR) ₪2.518 ₪176.34M ★★★★★★ Oil Refineries (TASE:ORL) ₪0.924 ₪2.87B ★★★★★☆ Tgi Infrastructures (TASE:TGI) ₪2.082 ₪154.78M ★★★★★★ Sharjah Cement and Industrial Development (PJSC) (ADX:SCIDC) AED0.695 AED422.74M ★★★★★★ Dubai National Insurance & Reinsurance (P.S.C.) (DFM:DNIR) AED3.42 AED395.01M ★★★★★★ E7 Group PJSC (ADX:E7) AED0.995 AED2.08B ★★★★★★ Dubai Investments PJSC (DFM:DIC) AED2.36 AED10.03B ★★★★☆☆ Click here to see the full list of 95 stocks from our Middle Eastern Penny Stocks screener. Let's dive into some prime choices out of the screener. Simply Wall St Financial Health Rating: ★★★★☆☆ Overview: Taaleem Holdings PJSC operates in the United Arab Emirates, focusing on providing and investing in education services, with a market cap of AED3.65 billion. Operations: The company generates revenue primarily from school operations, amounting to AED1.05 billion. Market Cap: AED3.65B Taaleem Holdings PJSC, with a market cap of AED3.65 billion, demonstrates potential within the penny stock segment in the Middle East due to its stable financial performance and strategic focus on education services. The company's recent earnings report shows a revenue increase to AED343.74 million for the second quarter of 2025, reflecting growth from AED282.54 million in the previous year. Despite a slight decline in net profit margin from 15.3% to 15.2%, Taaleem maintains robust debt management with operating cash flow covering 59.3% of its debt and interest coverage at 49.6 times EBIT, indicating financial resilience and prudent fiscal strategy. Jump into the full analysis health report here for a deeper understanding of Taaleem Holdings PJSC. Learn about Taaleem Holdings PJSC's future growth trajectory here. Simply Wall St Financial Health Rating: ★★★★★☆ Overview: Airtouch Solar Ltd offers autonomous water-free robotic cleaning solutions for solar panels and has a market cap of ₪32.20 million. Operations: The company generates revenue from its Industrial Automation & Controls segment, totaling ₪45.32 million. Market Cap: ₪32.2M Airtouch Solar Ltd, with a market cap of ₪32.20 million, has shown significant revenue growth, reaching ₪45.32 million from the previous year's ₪16.26 million. Despite this increase, the company remains unprofitable with a net loss of ₪5.46 million for 2024. The company's short-term assets of ₪42.5M comfortably cover both its short and long-term liabilities, while its cash reserves exceed total debt levels, providing financial stability amid high share price volatility over recent months. The management team and board are experienced but face challenges in reversing negative earnings trends and improving return on equity currently at -23.04%. Get an in-depth perspective on Airtouch Solar's performance by reading our balance sheet health report here. Review our historical performance report to gain insights into Airtouch Solar's track record. Simply Wall St Financial Health Rating: ★★★★★☆ Overview: Novolog (Pharm-Up 1966) Ltd operates in the healthcare services sector in Israel with a market cap of ₪794.87 million. Operations: The company generates revenue from its Logistics Division with ₪1.79 billion, the Health Services Division contributing ₪206.73 million, and the Digital Division adding ₪26.31 million. Market Cap: ₪794.87M Novolog (Pharm-Up 1966) Ltd, with a market cap of ₪794.87 million, has transitioned to profitability, reporting net income of ₪39.54 million for 2024 compared to a loss the previous year. The company's revenue rose to ₪2.02 billion from its Logistics and Health Services divisions primarily. Despite becoming profitable, Novolog's earnings have declined by an average of 22.8% annually over five years and its return on equity remains low at 10.7%. The company is debt-free but faces challenges as short-term assets slightly undercut short-term liabilities by ₪100 million, while the board lacks extensive experience with an average tenure of 2.5 years. Navigate through the intricacies of Novolog (Pharm-Up 1966) with our comprehensive balance sheet health report here. Explore historical data to track Novolog (Pharm-Up 1966)'s performance over time in our past results report. Access the full spectrum of 95 Middle Eastern Penny Stocks by clicking on this link. Interested In Other Possibilities? Find companies with promising cash flow potential yet trading below their fair value. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include DFM:TAALEEM TASE:ARTS and TASE:NVLG. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
